RESOLUTE ONYX Post-Approval Study

Completed

Conditions studied: Coronary Artery Disease

In brief

To observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population.

Key facts

Study ID
NCT03063749
Run by
Medtronic Vascular
People needed
416
Starts
2017-03-30
Expected to finish
2022-08-18
Last updated by the study team
2023-11-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.